|
US1984A
(en)
|
|
1841-02-18 |
|
Machinery for trimming straw braid |
|
US5326859A
(en)
|
1979-10-30 |
1994-07-05 |
Juridical Foundation, Japanese Foundation For Cancer Research |
DNA and recombinant plasmid
|
|
US4405712A
(en)
|
1981-07-01 |
1983-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
LTR-Vectors
|
|
AU561343B2
(en)
|
1981-10-19 |
1987-05-07 |
Genentech Inc. |
Human immune interferon by recombinant dna
|
|
US5364773A
(en)
*
|
1991-03-07 |
1994-11-15 |
Virogenetics Corporation |
Genetically engineered vaccine strain
|
|
EP0091539B2
(en)
|
1982-03-31 |
1996-11-27 |
Ajinomoto Co., Inc. |
Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells
|
|
US4853332A
(en)
|
1982-10-19 |
1989-08-01 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
|
|
US4966843A
(en)
|
1982-11-01 |
1990-10-30 |
Cetus Corporation |
Expression of interferon genes in Chinese hamster ovary cells
|
|
US4876197A
(en)
|
1983-02-22 |
1989-10-24 |
Chiron Corporation |
Eukaryotic regulatable transcription
|
|
US4518584A
(en)
*
|
1983-04-15 |
1985-05-21 |
Cetus Corporation |
Human recombinant interleukin-2 muteins
|
|
US5843638A
(en)
*
|
1983-12-05 |
1998-12-01 |
Institut Pasteur And Centre National De La Recherche Scientifique |
Nucleic acids and pepties of human immunodeficiency virus type-1 (HIV-1).
|
|
US4892743A
(en)
|
1983-12-21 |
1990-01-09 |
Schering Corporation |
Novel hybrid interferon species
|
|
EP0165942A1
(en)
|
1983-12-23 |
1986-01-02 |
Monash University |
PRODUCTION OF HUMAN INTERFERON-$g(a)
|
|
AU594014B2
(en)
|
1984-03-21 |
1990-03-01 |
Research Corporation Technologies, Inc. |
Recombinant DNA molecules
|
|
US6610476B1
(en)
*
|
1984-08-22 |
2003-08-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Detection of HIV-1 DNA
|
|
US5032510A
(en)
*
|
1984-09-26 |
1991-07-16 |
Eli Lilly And Company |
Method for expression and secretion in bacillus
|
|
US5100792A
(en)
|
1984-11-13 |
1992-03-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues
|
|
US4945050A
(en)
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US5036006A
(en)
|
1984-11-13 |
1991-07-30 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US4847201A
(en)
|
1985-02-05 |
1989-07-11 |
Cetus Corporation |
DNA encoding for CSF-1 and accompanying recombinant systems
|
|
US5185444A
(en)
|
1985-03-15 |
1993-02-09 |
Anti-Gene Deveopment Group |
Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
|
|
JP2528107B2
(ja)
|
1985-03-15 |
1996-08-28 |
サマ−トン，ジエ−ムス |
ポリヌクレオチド測定試薬と方法
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4663161A
(en)
|
1985-04-22 |
1987-05-05 |
Mannino Raphael J |
Liposome methods and compositions
|
|
US4871488A
(en)
|
1985-04-22 |
1989-10-03 |
Albany Medical College Of Union University |
Reconstituting viral glycoproteins into large phospholipid vesicles
|
|
US4810643A
(en)
|
1985-08-23 |
1989-03-07 |
Kirin- Amgen Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
|
JPS63500636A
(ja)
|
1985-08-23 |
1988-03-10 |
麒麟麦酒株式会社 |
多分化能性顆粒球コロニー刺激因子をコードするｄｎａ
|
|
US4777127A
(en)
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5017691A
(en)
|
1986-07-03 |
1991-05-21 |
Schering Corporation |
Mammalian interleukin-4
|
|
US4800159A
(en)
|
1986-02-07 |
1989-01-24 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences
|
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
US4879227A
(en)
|
1986-05-06 |
1989-11-07 |
Genetics Institute, Inc. |
Production of a recombinant human colony stimulating factor
|
|
US5034511A
(en)
*
|
1987-04-13 |
1991-07-23 |
Institut Pasteur |
Variant of LAV viruses
|
|
US5135855A
(en)
|
1986-09-03 |
1992-08-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
Rapid, versatile and simple system for expressing genes in eukaryotic cells
|
|
GB8702816D0
(en)
|
1987-02-07 |
1987-03-11 |
Al Sumidaie A M K |
Obtaining retrovirus-containing fraction
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
US4980289A
(en)
|
1987-04-27 |
1990-12-25 |
Wisconsin Alumni Research Foundation |
Promoter deficient retroviral vector
|
|
US5256767A
(en)
*
|
1987-06-10 |
1993-10-26 |
The Immune Response Corporation |
Retroviral antigens
|
|
US5637677A
(en)
*
|
1987-07-16 |
1997-06-10 |
The Trustees Of The University Of Pennsylvania |
Biologically active compounds and methods of constructing and using the same
|
|
US5128319A
(en)
*
|
1987-08-28 |
1992-07-07 |
Board Of Regents, The University Of Texas System |
Prophylaxis and therapy of acquired immunodeficiency syndrome
|
|
DE10399032I1
(de)
|
1987-08-28 |
2004-01-29 |
Health Research Inc |
Rekombinante Viren.
|
|
HK1008049A1
(en)
|
1987-09-11 |
1999-04-30 |
Whitehead Institute For Biomedical Research |
Transduced fibroblasts and use therefor
|
|
US5879907A
(en)
*
|
1987-09-14 |
1999-03-09 |
Skandigen Ab |
Artificial gene coding for authentic human serum albumin, use thereof and method
|
|
US4965195A
(en)
|
1987-10-26 |
1990-10-23 |
Immunex Corp. |
Interleukin-7
|
|
US5714596A
(en)
*
|
1987-11-18 |
1998-02-03 |
Chiron Corporation |
NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
|
|
US5683864A
(en)
|
1987-11-18 |
1997-11-04 |
Chiron Corporation |
Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
|
|
US5712088A
(en)
|
1987-11-18 |
1998-01-27 |
Chiron Corporation |
Methods for detecting Hepatitis C virus using polynucleotides specific for same
|
|
WO1989005349A1
(en)
|
1987-12-09 |
1989-06-15 |
The Australian National University |
Method of combating viral infections
|
|
US5179022A
(en)
|
1988-02-29 |
1993-01-12 |
E. I. Du Pont De Nemours & Co. |
Biolistic apparatus for delivering substances into cells and tissues in a non-lethal manner
|
|
CN1038306A
(zh)
|
1988-03-21 |
1989-12-27 |
维吉恩公司 |
重组反转录病毒
|
|
AP129A
(en)
|
1988-06-03 |
1991-04-17 |
Smithkline Biologicals S A |
Expression of retrovirus gag protein eukaryotic cells
|
|
WO1990002806A1
(en)
|
1988-09-01 |
1990-03-22 |
Whitehead Institute For Biomedical Research |
Recombinant retroviruses with amphotropic and ecotropic host ranges
|
|
WO1990002568A1
(en)
|
1988-09-13 |
1990-03-22 |
Chiron Corporation |
Hiv-1 envelope muteins lacking hypervariable domains
|
|
CA2004261A1
(en)
|
1988-12-01 |
1990-06-01 |
Charles T. Tackney |
Synthetic interleukin-6
|
|
EP0832980B1
(en)
|
1989-01-23 |
2002-06-19 |
Chiron Corporation |
Recombinant therapies for infection and hyperproliferative disorders
|
|
US5665577A
(en)
*
|
1989-02-06 |
1997-09-09 |
Dana-Farber Cancer Institute |
Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof
|
|
DK0737750T3
(da)
|
1989-03-21 |
2003-09-01 |
Vical Inc |
Ekspression af exogene polynucleotidsekvenser i vertebrater
|
|
US6214804B1
(en)
*
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
WO1990014837A1
(en)
|
1989-05-25 |
1990-12-13 |
Chiron Corporation |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
EP1001032A3
(en)
|
1989-08-18 |
2005-02-23 |
Chiron Corporation |
Recombinant retroviruses delivering vector constructs to target cells
|
|
GB8919607D0
(en)
|
1989-08-30 |
1989-10-11 |
Wellcome Found |
Novel entities for cancer therapy
|
|
DE69019291T2
(de)
*
|
1989-10-23 |
1995-09-21 |
F. Hoffmann-La Roche Ag, Basel |
Synthetische HTLV-I Hüll-Peptide.
|
|
FR2658432B1
(fr)
|
1990-02-22 |
1994-07-01 |
Medgenix Group Sa |
Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation.
|
|
ATE183235T1
(de)
|
1990-03-21 |
1999-08-15 |
Wolf Hans Joachim Prof Dr |
Für abgeänderte retrovirale gag-polypeptide kodierende dna-sequenzen und diese enthaltende impfstoffe oder aggregate davon
|
|
AU8200191A
(en)
|
1990-07-09 |
1992-02-04 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
High efficiency packaging of mutant adeno-associated virus using amber suppressions
|
|
WO1992001800A1
(en)
|
1990-07-20 |
1992-02-06 |
Chiron Corporation |
Method for integrative transformation of yeast using dispersed repetitive elements
|
|
MY109299A
(en)
|
1990-08-15 |
1996-12-31 |
Virogenetics Corp |
Recombinant pox virus encoding flaviviral structural proteins
|
|
US5840313A
(en)
*
|
1990-09-27 |
1998-11-24 |
Syntello Vaccine Development Kb |
Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
DE69129154T2
(de)
*
|
1990-12-03 |
1998-08-20 |
Genentech, Inc., South San Francisco, Calif. |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
PT100090A
(pt)
*
|
1991-02-04 |
1993-07-30 |
Univ Saskatchewan |
Metodo de preparacao de uma composicao capz de libertar um agente biologicamente activo para um alvo, e de encapsulacao do referido agente em esferas da proteina vp6
|
|
JPH06508821A
(ja)
*
|
1991-03-07 |
1994-10-06 |
セラジュン インク |
ウイルス病治療のための細胞表面受容体を標的とする分子の使用
|
|
IL101715A
(en)
|
1991-05-02 |
2005-06-19 |
Amgen Inc |
Recombinant dna-derived cholera toxin subunit analogs
|
|
ATE237694T1
(de)
|
1991-08-20 |
2003-05-15 |
Us Gov Health & Human Serv |
Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
|
|
US5558865A
(en)
*
|
1991-08-22 |
1996-09-24 |
Nissin Shokuhin Kabushiki Kaisha |
HIV immunotherapeutics
|
|
DK0608261T3
(da)
*
|
1991-09-13 |
2003-03-17 |
Chiron Corp |
Sammensætninger med immunreaktivt hepatitis C virus polypeptid
|
|
WO1993010218A1
(en)
|
1991-11-14 |
1993-05-27 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Vectors including foreign genes and negative selective markers
|
|
GB9125623D0
(en)
|
1991-12-02 |
1992-01-29 |
Dynal As |
Cell modification
|
|
IT1253009B
(it)
|
1991-12-31 |
1995-07-10 |
Sclavo Ricerca S R L |
Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
|
|
US6174666B1
(en)
*
|
1992-03-27 |
2001-01-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of eliminating inhibitory/instability regions from mRNA
|
|
CA2084386C
(en)
*
|
1992-06-04 |
2001-02-20 |
Atsushi Saito |
Hiv antigen
|
|
EP0650370A4
(en)
|
1992-06-08 |
1995-11-22 |
Univ California |
METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES.
|
|
EP0644946A4
(en)
|
1992-06-10 |
1997-03-12 |
Us Health |
VECTOR PARTICLES RESISTANT TO INACTIVATION BY HUMAN SERUM.
|
|
DE69319120T2
(de)
|
1992-07-27 |
1999-01-07 |
New York University, New York, N.Y. |
Magnetstruktur mit hoher feldstärke
|
|
GB2269175A
(en)
|
1992-07-31 |
1994-02-02 |
Imperial College |
Retroviral vectors
|
|
US5663169A
(en)
*
|
1992-08-07 |
1997-09-02 |
Merck & Co., Inc. |
Benzoxazinones as inhibitors of HIV reverse transcriptase
|
|
DE4228458A1
(de)
*
|
1992-08-27 |
1994-06-01 |
Beiersdorf Ag |
Multicistronische Expressionseinheiten und deren Verwendung
|
|
US6004763A
(en)
*
|
1992-09-11 |
1999-12-21 |
Institut Pasteur |
Antigen-carrying microparticles and their use in the induction of humoral or cellular responses
|
|
FR2695563B1
(fr)
*
|
1992-09-11 |
1994-12-02 |
Pasteur Institut |
Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
|
|
US5686078A
(en)
*
|
1992-09-14 |
1997-11-11 |
Connaught Laboratories, Inc. |
Primary and secondary immunization with different physio-chemical forms of antigen
|
|
CA2105629A1
(en)
*
|
1992-09-14 |
1994-03-15 |
Robert S. Becker |
Potentiation of immunogenic response
|
|
US5831005A
(en)
|
1992-09-24 |
1998-11-03 |
Chiron Corporation |
Synthesis of N-substituted oligomers
|
|
US5304472A
(en)
*
|
1992-11-20 |
1994-04-19 |
Genentech, Inc. |
Method of controlling polypeptide production in bacterial cells
|
|
ATE199392T1
(de)
*
|
1992-12-04 |
2001-03-15 |
Medical Res Council |
Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
|
|
US6140059A
(en)
*
|
1993-01-16 |
2000-10-31 |
Schawaller; Manfred |
Methods for the obtention of human immunodeficiency virsus Type 1 envelope glycoproteins in native and oligomeric form employing recombinant chimeric antigens containing collagenase recognition sites.
|
|
US5593972A
(en)
*
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
|
US5591601A
(en)
|
1993-05-14 |
1997-01-07 |
Ohio University Edison Animal Biotechnology Institute |
DNA polymerase gene expression system utilizing an RNA polymerase co-delivered with the gene expression vector system
|
|
US5419900A
(en)
*
|
1993-05-19 |
1995-05-30 |
The United States Of America As Represented By The Department Of Of Health And Human Services |
Immunologic enhancement with intermittent interleukin-2 therapy
|
|
WO1994028929A1
(en)
*
|
1993-06-07 |
1994-12-22 |
Genentech, Inc. |
Hiv envelope polypeptides
|
|
AU693098B2
(en)
|
1993-06-09 |
1998-06-25 |
Connaught Laboratories Limited |
Tandem synthetic HIV-1 peptides
|
|
US5614413A
(en)
*
|
1993-07-01 |
1997-03-25 |
The Uab Research Foundation |
Encapsidated recombinant poliovirus nucleic acid and methods of making and using same
|
|
US5834441A
(en)
|
1993-09-13 |
1998-11-10 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Adeno-associated viral (AAV) liposomes and methods related thereto
|
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
|
US5955342A
(en)
*
|
1994-08-15 |
1999-09-21 |
Connaught Laboratories Limited |
Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
|
|
US6291157B1
(en)
*
|
1998-02-23 |
2001-09-18 |
Connaught Laboratories Limited |
Antigenically-marked non-infectious retrovirus-like particles
|
|
US6080408A
(en)
*
|
1994-08-22 |
2000-06-27 |
Connaught Laboratories Limited |
Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
|
|
US5676950A
(en)
|
1994-10-28 |
1997-10-14 |
University Of Florida |
Enterically administered recombinant poxvirus vaccines
|
|
WO1996017072A2
(en)
|
1994-11-30 |
1996-06-06 |
Chiron Viagene, Inc. |
Recombinant alphavirus vectors
|
|
US5550280A
(en)
*
|
1994-11-30 |
1996-08-27 |
Uniroyal Chemical Ltd./ Uniroyal Chemical Ltee |
Hindered aromatic ester compounds useful as anti-viral agents
|
|
ES2176360T3
(es)
|
1994-12-30 |
2002-12-01 |
Chiron Corp |
Combinacion de vehiculos de administracion de genes.
|
|
US5962428A
(en)
*
|
1995-03-30 |
1999-10-05 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
CN1185811A
(zh)
|
1995-03-31 |
1998-06-24 |
H·沃尔夫 |
依赖于逆转录病毒样颗粒的抗原呈递系统
|
|
CU22559A1
(es)
*
|
1996-01-17 |
1999-05-03 |
Ct Ingenieria Genetica Biotech |
Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
|
|
US5741492A
(en)
|
1996-01-23 |
1998-04-21 |
St. Jude Children's Research Hospital |
Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
|
|
US6087486A
(en)
*
|
1996-01-29 |
2000-07-11 |
The Trustees Of The University Of Pennsylvania |
Nucleotide sequences encoding vpr receptor protein
|
|
US6060587A
(en)
*
|
1996-01-29 |
2000-05-09 |
The Trustees Of The University Of Pennsylvania |
Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
|
|
US6451592B1
(en)
|
1996-04-05 |
2002-09-17 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
|
ES2301178T3
(es)
|
1996-04-05 |
2008-06-16 |
Novartis Vaccines & Diagnostic |
Vectores basados en alfavirus recombinantes con inhibicion reducida de la sintesis macromolecular celular.
|
|
US5951975A
(en)
*
|
1996-06-28 |
1999-09-14 |
University Of Pittsburgh |
Induction of CTLs specific for natural antigens by cross priming immunization
|
|
CA2265889A1
(en)
*
|
1996-09-06 |
1998-03-12 |
The Regents Of The University Of California |
E25a protein, methods for production and use thereof
|
|
US6114148C1
(en)
*
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
|
US6139833A
(en)
*
|
1997-08-08 |
2000-10-31 |
Lexicon Genetics Incorporated |
Targeted gene discovery
|
|
EE9900343A
(et)
|
1997-02-07 |
2000-02-15 |
Merck & Co., Inc. |
Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon
|
|
US5858675A
(en)
*
|
1997-05-13 |
1999-01-12 |
Incyte Pharmaceuticals, Inc. |
Double-stranded RNA-binding protein
|
|
US6099847A
(en)
*
|
1997-05-15 |
2000-08-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Chimeric Gag pseudovirions
|
|
US6846905B2
(en)
*
|
1997-08-15 |
2005-01-25 |
Abbott Laboratories |
Antigen constructs useful in the detection and differentiation of antibodies to HIV
|
|
US5932442A
(en)
*
|
1997-09-23 |
1999-08-03 |
Incyte Pharmaceuticals, Inc. |
Human regulatory molecules
|
|
US5932445A
(en)
*
|
1997-11-07 |
1999-08-03 |
Incyte Pharmaceuticals, Inc. |
Signal peptide-containing proteins
|
|
WO1999053046A2
(en)
*
|
1998-04-14 |
1999-10-21 |
Chiron Corporation |
Noncloning technique for expressing a gene of interest
|
|
WO2000011140A1
(en)
*
|
1998-08-20 |
2000-03-02 |
The Wistar Institute Of Anatomy And Biology |
Methods of augmenting mucosal immunity through systemic priming and mucosal boosting
|
|
AU2221600A
(en)
*
|
1998-12-31 |
2000-07-31 |
Chiron Corporation |
Improved expression of hiv polypeptides and production of virus-like particles
|
|
ATE384795T1
(de)
*
|
1998-12-31 |
2008-02-15 |
Novartis Vaccines & Diagnostic |
Modifizierte hiv env polypeptide
|
|
EP1141314A2
(en)
|
1998-12-31 |
2001-10-10 |
Chiron Corporation |
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
|
|
US7935805B1
(en)
*
|
1998-12-31 |
2011-05-03 |
Novartis Vaccines & Diagnostics, Inc |
Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
|
|
EP1228237A1
(en)
*
|
1999-11-01 |
2002-08-07 |
Chiron Corporation |
Expression vectors, transfection systems, and method of use thereof
|
|
US6733993B2
(en)
*
|
2000-09-15 |
2004-05-11 |
Merck & Co., Inc. |
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications
|
|
EP1409694A4
(en)
*
|
2001-07-05 |
2006-02-08 |
Chiron Corp |
POLYNUCLEOTIDES ENCODING ANTIGENIC POLYPEPTIDES OF HIV SUBTYPE B AND / OR SUBTYPE C, POLYPEPTIDES AND USES THEREOF
|
|
US7800921B2
(en)
|
2007-01-08 |
2010-09-21 |
Continental Automotive Systems Us, Inc. |
DC/DC converter
|
|
CN102847538B
(zh)
|
2007-07-06 |
2016-07-06 |
M技术株式会社 |
由球碳形成的结晶的制造方法及制造装置
|
|
EP2510962A1
(en)
|
2011-04-12 |
2012-10-17 |
F. Hoffmann-La Roche AG |
Infusion pump device with re-filling scheme for cylinder-piston dosing unit
|